Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T22:36:19.766Z Has data issue: false hasContentIssue false

Chapter 23 - Complications of Inflammatory Bowel Disease

Published online by Cambridge University Press:  06 June 2020

Roger M. Feakins
Affiliation:
Royal Free London NHS Foundation Trust, London, UK
Get access

Summary

Various intestinal and extraintestinal conditions may complicate inflammatory bowel disease (IBD). Intestinal complications include infections, strictures, obstruction, fistulas, dysplasia, and malignancy. Extraintestinal complications or associations include cutaneous disease, arthropathy, ocular problems, primary sclerosing cholangitis, and other forms of liver disease. The intestinal complications whose diagnosis and assessment relies most heavily on histopathology are cytomegalovirus (CMV) infection, dysplasia, and malignancy. Reactivation of latent CMV is more likely in ulcerative colitis than Crohn’s disease, is more common in those with immunosuppression and/or severe disease, and is associated with a worse clinical outcome. CMV inclusions are often detectable on H&E examination. Immunohistochemistry for CMV is specific and sensitive. Histopathology may also play a role in recognising other infections such as amoebiasis and TB and may contribute to the assessment of fissures and fistulas. Confident recognition of dysplasia depends on histology, although endoscopic methods of detection are becoming more reliable. Colorectal carcinoma (CRC) is the most common malignancy to complicate IBD and is more likely than non-IBD CRC to present at a younger age and to be right-sided and is more likely to show signet ring cell differentiation, a peritumoral lymphocytic reaction, and a mucinous phenotype. Small bowel cancer may complicate Crohn’s disease but is rare overall. A lymphoproliferative disorder may complicate IBD, especially in the setting of thiopurine therapy.

Type
Chapter
Information
Non-Neoplastic Pathology of the Gastrointestinal Tract
A Practical Guide to Biopsy Diagnosis
, pp. 388 - 400
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sokol, H, Lalande, V, Landman, C, et al. Clostridium difficile infection in acute flares of inflammatory bowel disease: a prospective study. Dig Liver Dis. 2017;49(6):643–6.Google Scholar
Pascal, V, Pozuelo, M, Borruel, N, et al. A microbial signature for Crohn’s disease. Gut. 2017;66(5):813–22.CrossRefGoogle ScholarPubMed
Sager, K, Alam, S, Bond, A, et al. Review article: cytomegalovirus and inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(8):725–33.Google Scholar
Ciccocioppo, R, Racca, F, Paolucci, S, et al. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. World J Gastroenterol. 2015;21(6):1915–26.Google Scholar
Magro, F, Langner, C, Driessen, A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7(10):827–51.Google Scholar
Geboes, K, Riddell, R, Jain, D. Inflammatory bowel diseases. In Riddell, R, Jain, D (eds), Lewin, Weinstein and Riddell’s Gastrointestinal Pathology and Its Clinical Implications.Philadelphia, PA: Lippincott Williams & Wilkins; 2014, 9831208.Google Scholar
Ryan, JL, Shen, YJ, Morgan, DR, et al. Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa. Dig Dis Sci. 2012;57(7):1887–98.Google Scholar
Nissen, LH, Nagtegaal, ID, de Jong, DJ, et al. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders. J Crohns Colitis. 2015;9(5):398403.Google Scholar
Pezhouh, MK, Miller, JA, Sharma, R, et al. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case controlled study using highly sensitive EBV encoded small RNA1 in situ hybridization. Hum Pathol. 2018; 82:187–92CrossRefGoogle Scholar
Verweij, JJ, van Lieshout, L. Intestinal parasitic infections in an industrialized country; a new focus on children with better DNA-based diagnostics. Parasitol. 2011;138(12):1492–8.Google Scholar
Ustun, S, Dagci, H, Aksoy, U, et al. Prevalence of amebiasis in inflammatory bowel disease in Turkey. World J Gastroenterol. 2003;9(8):1834–5.CrossRefGoogle ScholarPubMed
Rampton, DS, Salmon, PR, Clark, CG. Nonspecific ulcerative colitis as a sequel to amebic dysentery. J Clin Gastroenterol. 1983;5(3):217–9.Google Scholar
Oberhuber, G, Mesteri, I, Kopf, W, Müller, H. Demonstration of trophozoites of G. lamblia in ileal mucosal biopsy specimens may reveal giardiasis in patients with significantly inflamed parasite-free duodenal mucosa. Am J Surg Pathol. 2016;40(9):1280–5.Google Scholar
Jain, D. Enteric infections and associated diseases. In Ridell, R, Jain, D (eds), Lewin, Weinstein and Riddell’s Gastrointestinal Pathology and Its Clinical Implications, Lippincott Williams & Wilkins: Philadelphia; 2014, 12091326.Google Scholar
Hartong, WA, Gourley, WK, Arvanitakis, C. Giardiasis: clinical spectrum and functional–structural abnormalities of the small intestinal mucosa. Gastroenterology. 1979;77(1):61–9.Google Scholar
Sinelnikov, I, Sion-Vardy, N, Shaco-Levy, R. C-kit (CD117) immunostain is useful for the diagnosis of Giardia lamblia in duodenal biopsies. Hum Pathol. 2009;40(3):323–5.CrossRefGoogle ScholarPubMed
Scheurlen, C, Kruis, W, Spengler, U, et al. Crohn’s disease is frequently complicated by giardiasis. Scand J Gastroenterol. 1988;23(7):833–9.Google Scholar
Goodman, MJ, Pearson, KW, McGhie, D, et al. Campylobacter and Giardia lamblia causing exacerbation of inflammatory bowel disease. Lancet. 1980;2(8206):1247.Google Scholar
Dellers, EA, Dunn, JC, deSantis, P, Aronchik, CA. Identification of Blastocystis hominis by colonic brush cytology: a case report. Acta Cytol. 1992;36(5):757–8.Google Scholar
Yamamoto-Furusho, JK, Torijano-Carrera, E. Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course. Digestion. 2010;82(1):1823.Google Scholar
Nagler, J, Brown, M, Soave, R. Blastocystis hominis in inflammatory bowel disease. J Clin Gastroenterol. 1993;16(2):109–12.CrossRefGoogle ScholarPubMed
Nitzan, O, Elias, M, Chazan, B, et al. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol. 2013; 19(43):7577–85.Google Scholar
Navaneethan, U, Mukewar, S, Venkatesh, PG, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis. 2012. 6(3):330–6.Google Scholar
McCurdy, JD, Enders, FT, Khanna, S, et al. Increased rates of Clostridium difficile infection and poor outcomes in patients with IBD with cytomegalovirus. Inflamm Bowel Dis. 2016; 22(11):2688–93.Google Scholar
Navarro-Llavat, M, Domènech, E, Bernal, I, et al. Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients. Digestion. 2009;80(1):25–9.CrossRefGoogle ScholarPubMed
Keane, J, Gershon, S, Wise, RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345(15):1098–104.Google Scholar
Singh, J, Puri, AS, Sachdeva, S, et al. Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis. Intest Res. 2016;14(2):183–6.Google Scholar
Kim, ES, Song, GA, Cho, KB, et al. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. World J Gastroenterol. 2015;21(11):3308–16.Google Scholar
Schwartz, DA, Loftus, EV Jr., Tremaine, WJ, et al. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122(4):875–80.Google Scholar
Scharl, M, Frei, S, Pesch, T, et al. Interleukin-13 and transforming growth factor beta synergise in the pathogenesis of human intestinal fistulae. Gut. 2013;62(1):6372.CrossRefGoogle ScholarPubMed
Bataille, F, Klebl, F, Rümmele, P, et al. Morphological characterisation of Crohn’s disease fistulae. Gut. 2004;53(9):1314–21.Google Scholar
Yu, H, Liu, Y, Wang, Y, et al. Clinical, endoscopic and histological differentiations between Crohn’s disease and intestinal tuberculosis. Digestion. 2012;85(3):202–9.CrossRefGoogle ScholarPubMed
Makharia, GK, Srivastava, S, Das, P, et al. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol. 2010;105(3):642–51.Google Scholar
de Zoeten, EF, Pasternak, BA, Mattei, P, et al. Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr. 2013; 57(3):401–12.Google Scholar
Plesec, TP, Owens, SR. Inflammatory and neoplastic disorders of the anal canal, In Odze, RD, Goldblum, JR (eds), Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Philadelphia: Saunders Elsevier; 2015, 887920.Google Scholar
Rutter, M, Saunders, B, Wilkinson, K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–9.Google Scholar
Gupta, RB, Harpaz, N, Itzkowitz, S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133(4):1099–105; quiz 1340–1.CrossRefGoogle ScholarPubMed
Liu, X, Goldblum, JR, Zhao, Z, et al. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma. Am J Surg Pathol. 2012;36(8):1228–33.Google Scholar
Harpaz, N, Ward, S, Mescoli, C, et al. Precancerous lesions in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2013;27(2):257–67.Google Scholar
Potack, J, Itzkowitz, SH. Colorectal cancer in inflammatory bowel disease. Gut Liver. 2008;2(2):6173.Google Scholar
Svrcek, M, Fontugne, J, Duval, A, Fléjou, JF. Inflammatory bowel disease-associated colorectal cancers and microsatellite instability: an original relationship. Am J Surg Pathol. 2013;37(3):460–2.Google Scholar
Jiang, W, Shadrach, B, Carver, P, et al. Histomorphologic and molecular features of pouch and peripouch adenocarcinoma: a comparison with ulcerative colitis-associated adenocarcinoma. Am J Surg Pathol. 2012;36(9):1385–94.Google Scholar
Cairns, SR, Scholefield, JH, Steele, RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–89.Google Scholar
Moussata, D, Allez, M, Cazals-Hatem, D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2018;67(4):616–24.Google Scholar
East, JE, Arkins, WS, Bateman, AC, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66(7):1181–96.Google Scholar
Bossard, C, Denis, MG, Bézieau, S, et al. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep. 2007;18(5):1093–7.Google Scholar
Shen, J, Gibson, JA, Schulte, S, et al. Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease. Hum Pathol. 2015;46(10):1548–56.Google Scholar
Johnson, DH, Khanna, S, Smyrk, TC, et al. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn’s colitis. Aliment Pharmacol Ther. 2014;39(12):1408–17.Google Scholar
Picco, MF. Serrated epithelial change as a precursor to colorectal cancer in inflammatory bowel disease: guilt by association? Gastrointest Endosc. 2016; 84(1):96–7.Google Scholar
Farrell, RJ, Ang, Y, Kileen, P, et al. Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut. 2000;47(4):514–19.Google Scholar
Herrinton, LJ, Liu, L, Weng, X, et al. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2011;106(12):2146–53.Google Scholar
Gordon, J, Ramaswami, A, Beuttler, M, et al. EBV status and thiopurine use in pediatric IBD. J Pediatr Gastroenterol Nutr. 2016;62(5):711–14.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×